This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Exostemtech Co., Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Woolee Cho: Innovator in Adipocyte Differentiation
Introduction
Woolee Cho is a prominent inventor based in Busan, South Korea. He has made significant contributions to the field of biotechnology, particularly in the area of adipocyte differentiation. His innovative work focuses on the use of stem cell-derived exosomes to induce the differentiation of beige adipocytes, which has potential implications for health and wellness.
Latest Patents
Woolee Cho holds a patent for a composition designed to induce beige adipocyte differentiation. The patent, titled "Composition for inducing beige adipocyte differentiation containing exosome derived from stem cells," outlines a method that utilizes exosomes derived from stem cells as an active ingredient. This composition can be used in pharmaceutical formulations, health functional foods, and differentiation media, providing a novel approach to promoting metabolic health.
Career Highlights
Woolee Cho is associated with Exostemtech Co., Ltd., where he continues to advance research in the field of stem cell technology and its applications. His work has garnered attention for its innovative approach to addressing metabolic disorders through cellular differentiation.
Collaborations
Some of Woolee Cho's notable coworkers include Yong Woo Cho and Ji Suk Choi. Their collaborative efforts contribute to the ongoing research and development at Exostemtech Co., Ltd., enhancing the potential impact of their findings in the scientific community.
Conclusion
Woolee Cho's contributions to the field of adipocyte differentiation highlight the importance of innovative research in biotechnology. His work not only advances scientific understanding but also opens new avenues for therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile